Adrian M. Zelazny

9.1k total citations · 2 hit papers
115 papers, 4.6k citations indexed

About

Adrian M. Zelazny is a scholar working on Epidemiology, Infectious Diseases and Small Animals. According to data from OpenAlex, Adrian M. Zelazny has authored 115 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Epidemiology, 56 papers in Infectious Diseases and 24 papers in Small Animals. Recurrent topics in Adrian M. Zelazny's work include Mycobacterium research and diagnosis (53 papers), Tuberculosis Research and Epidemiology (26 papers) and Antifungal resistance and susceptibility (22 papers). Adrian M. Zelazny is often cited by papers focused on Mycobacterium research and diagnosis (53 papers), Tuberculosis Research and Epidemiology (26 papers) and Antifungal resistance and susceptibility (22 papers). Adrian M. Zelazny collaborates with scholars based in United States, Brazil and Israel. Adrian M. Zelazny's co-authors include Steven M. Holland, Patrick R. Murray, Steven K. Drake, Frida Stock, Yvonne R. Shea, Julia A. Segre, Kenneth N. Olivier, Tara N. Palmore, Evan S. Snitkin and Patricia S. Conville and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Adrian M. Zelazny

111 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing

2012 647 citations Evan S. Snitkin, Adrian M. Zelazny et al. Science Translational Medicine profile →
Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory

2020 208 citations Adrian M. Zelazny et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adrian M. Zelazny United States	37	2.4k	1.9k	1.1k	930	680	115	4.6k
Nancy L. Wengenack United States	40	3.1k 1.3×	2.7k 1.4×	850 0.8×	737 0.8×	572 0.8×	124	5.1k
Jean‐Louis Gaillard France	43	3.5k 1.5×	2.8k 1.5×	984 0.9×	1.4k 1.5×	98 0.1×	77	5.9k
Corné H. W. Klaassen Netherlands	47	2.7k 1.1×	4.7k 2.5×	1.9k 1.8×	677 0.7×	720 1.1×	184	8.5k
Nongnuch Vanittanakom Thailand	31	1.7k 0.7×	1.5k 0.8×	1.3k 1.2×	596 0.6×	83 0.1×	82	3.8k
Yingchun Xu China	38	1.7k 0.7×	1.6k 0.8×	911 0.8×	124 0.1×	698 1.0×	179	4.2k
Alex van Belkum Netherlands	32	1.8k 0.8×	1.4k 0.7×	777 0.7×	125 0.1×	386 0.6×	67	3.7k
H. Monteil France	45	891 0.4×	2.9k 1.5×	2.1k 1.9×	155 0.2×	864 1.3×	247	6.1k
Amin Kabani Canada	29	1.3k 0.6×	1.4k 0.7×	557 0.5×	422 0.5×	267 0.4×	73	2.7k
Éric Dannaoui France	47	4.8k 2.0×	5.8k 3.1×	606 0.6×	1000 1.1×	186 0.3×	173	7.4k
Jakko van Ingen Netherlands	52	7.0k 3.0×	5.8k 3.1×	902 0.8×	2.8k 3.0×	128 0.2×	247	8.4k

Countries citing papers authored by Adrian M. Zelazny

Since Specialization

Citations

This map shows the geographic impact of Adrian M. Zelazny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian M. Zelazny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian M. Zelazny more than expected).

Fields of papers citing papers by Adrian M. Zelazny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian M. Zelazny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian M. Zelazny. The network helps show where Adrian M. Zelazny may publish in the future.

Co-authorship network of co-authors of Adrian M. Zelazny

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian M. Zelazny. A scholar is included among the top collaborators of Adrian M. Zelazny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian M. Zelazny. Adrian M. Zelazny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown‐Elliott, Barbara A., Joseph O. Falkinham, David E. Griffith, et al.. (2025). Laboratory diagnosis of nontuberculous mycobacteria – an update – Part 1★: Epidemiology, environment sources, and guidance for the provider. Clinical Microbiology Newsletter. 52. 31–43.

Conlan, Sean, Poorani Subramanian, Jung-Ho Youn, et al.. (2024). Whole-genome sequence of Mucor velutinosus NIH1002, a strain associated with disseminated disease. Microbiology Resource Announcements. 13(7). e0006224–e0006224.

Shallom, Shamira J., et al.. (2022). Disulfiram Is Effective against Drug-Resistant Mycobacterium abscessus in a Zebrafish Embryo Infection Model. Antimicrobial Agents and Chemotherapy. 66(11). e0053922–e0053922. 3 indexed citations

Drummond, Rebecca A., Jigar V. Desai, Emily Ricotta, et al.. (2022). Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria. Cell Host & Microbe. 30(7). 1020–1033.e6. 75 indexed citations

Zhan, Lingpeng, Yifan He, Christopher J. Lyon, et al.. (2022). Peptidomic analysis of mycobacterial secreted proteins enables species identification. SHILAP Revista de lepidopterología. 3(4). 14 indexed citations

Davidson, Rebecca M., Jeanne Benoit, Nabeeh A. Hasan, et al.. (2021). Genomic characterization of sporadic isolates of the dominant clone of Mycobacterium abscessus subspecies massiliense. Scientific Reports. 11(1). 15336–15336. 18 indexed citations

Das, Sanchita Basu, Valeria De Giorgi, David K. Henderson, et al.. (2020). Pooled Saliva Specimens for SARS-CoV-2 Testing. Journal of Clinical Microbiology. 59(3). 46 indexed citations

Silva, J., et al.. (2020). Antimicrobial peptides against drug resistant Mycobacterium abscessus. Research in Microbiology. 171(5-6). 211–214. 9 indexed citations

Robinson, C., Sandra D. MacDonald, Ann M. Peterson, et al.. (2020). Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease. Access Microbiology. 2(9). acmi000154–acmi000154. 28 indexed citations

10.

Fleshner, Monika, K.N. Olivier, Pamela A. Shaw, et al.. (2016). Mortality among patients with pulmonary non-tuberculous mycobacteria disease. The International Journal of Tuberculosis and Lung Disease. 20(5). 582–587. 63 indexed citations

11.

Fowler, Cedar, Kenneth N. Olivier, Janice M. Leung, et al.. (2013). Abnormal Nasal Nitric Oxide Production, Ciliary Beat Frequency, and Toll-like Receptor Response in Pulmonary Nontuberculous Mycobacterial Disease Epithelium. American Journal of Respiratory and Critical Care Medicine. 187(12). 1374–1381. 57 indexed citations

12.

Snitkin, Evan S., Adrian M. Zelazny, Pamela J. Thomas, et al.. (2012). Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing. Science Translational Medicine. 4(148). 148ra116–148ra116. 647 indexed citations breakdown →

13.

Sugui, Janyce A., et al.. (2011). Hematogenously Disseminated Skin Disease Caused by Mucor velutinosus in a Patient with Acute Myeloid Leukemia. Journal of Clinical Microbiology. 49(7). 2728–2732. 17 indexed citations

14.

Sugui, Janyce A., Donald C. Vinh, Glenn Nardone, et al.. (2009). Neosartorya udagawae ( Aspergillus udagawae ), an Emerging Agent of Aspergillosis: How Different Is It from Aspergillus fumigatus ?. Journal of Clinical Microbiology. 48(1). 220–228. 63 indexed citations

15.

Zelazny, Adrian M., et al.. (2007). Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis. Clinical Microbiology and Infection. 13(9). 943–946. 7 indexed citations

16.

Greenberg, David E., Li Ding, Adrian M. Zelazny, et al.. (2006). A Novel Bacterium Associated with Lymphadenitis in a Patient with Chronic Granulomatous Disease. PLoS Pathogens. 2(4). e28–e28. 55 indexed citations

17.

Freeman, Alexandra F., et al.. (2006). LINEZOLID-RESISTANT STAPHYLOCOCCUS AUREUS IN TWO PEDIATRIC PATIENTS RECEIVING LOW-DOSE LINEZOLID THERAPY. The Pediatric Infectious Disease Journal. 25(6). 562–564. 40 indexed citations

18.

Zelazny, Adrian M., et al.. (2006). Invasive nontypeable Haemophilus influenzae infection in an adult with laryngeal cancer. Diagnostic Microbiology and Infectious Disease. 55(1). 85–87. 7 indexed citations

19.

Conz, Charlotte, Elke Deuerling, Dana Boyd, et al.. (2005). Target-directed proteolysis at the ribosome. Proceedings of the National Academy of Sciences. 102(12). 4246–4251. 20 indexed citations

20.

Zelazny, Adrian M., Leslie B. Calhoun, Li Li, Yvonne R. Shea, & Steven H. Fischer. (2005). Identification of Mycobacterium Species by secA1 Sequences. Journal of Clinical Microbiology. 43(3). 1051–1058. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact